<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34917368</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2050-0904</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>9</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical case reports</Title>
          <ISOAbbreviation>Clin Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Treatment of Morgellons disease with doxycycline.</ArticleTitle>
        <Pagination>
          <StartPage>e05148</StartPage>
          <MedlinePgn>e05148</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e05148</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ccr3.5148</ELocationID>
        <Abstract>
          <AbstractText>Morgellons disease (MD) is a rare dermatopathy characterized by nonspecific symptoms and the production of multicolored fibers and granular tissue from diffuse skin ulcerations which are described as being either pruritic or painful. The etiology of MD is currently unknown; previous studies have suggested both psychiatric and infectious causes, with increasing interest over the previous decade in elaborating a possible pathogenesis for the disease secondary to infection by Borrelia species. We report a middle-aged Caucasian female who developed symptoms of MD in the days following exposure to a tick bite after spending an afternoon hiking through a wooded area. She was subsequently treated with a course of Doxycycline and found on two-week follow-up to have complete remission of her symptoms. This case report further supports the theory for an infectious etiology of MD and encourages future studies into its pathophysiology.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. Clinical Case Reports published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jeff F</ForeName>
            <Initials>JF</Initials>
            <Identifier Source="ORCID">0000-0003-0898-5871</Identifier>
            <AffiliationInfo>
              <Affiliation>Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gopalakrishnan</LastName>
            <ForeName>Keerthy</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>SRM Medical College Hospital and Research Centre Kattankulathur Kanchipuram India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Molloy</LastName>
            <ForeName>Daniel J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>St. Vincent Health Center, Sisters of Charity Hospital Buffalo New York USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Case Rep</MedlineTA>
        <NlmUniqueID>101620385</NlmUniqueID>
        <ISSNLinking>2050-0904</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Borrelia burgdorferi</Keyword>
        <Keyword MajorTopicYN="N">Doxycycline</Keyword>
        <Keyword MajorTopicYN="N">Lyme disease</Keyword>
        <Keyword MajorTopicYN="N">Morgellons disease</Keyword>
        <Keyword MajorTopicYN="N">dermatopathology</Keyword>
        <Keyword MajorTopicYN="N">spirochetes</Keyword>
      </KeywordList>
      <CoiStatement>The authors of this manuscript declare no conflicts of interest involving any of the materials or findings related to this research project.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>56</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34917368</ArticleId>
        <ArticleId IdType="pmc">PMC8643125</ArticleId>
        <ArticleId IdType="doi">10.1002/ccr3.5148</ArticleId>
        <ArticleId IdType="pii">CCR35148</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Robles DT, Olson JM, Combs H, Romm S, Kirby P. Morgellons disease and delusions of parasitosis. Am J Clin Dermatol. 2011;12(1):1‐6. doi:10.2165/11533150-000000000-00000
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/11533150-000000000-00000</ArticleId>
            <ArticleId IdType="pubmed">21110523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatol Rep. 2018;10(1):7660. doi:10.4081/dr.2018.7660
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/dr.2018.7660</ArticleId>
            <ArticleId IdType="pmc">PMC5941186</ArticleId>
            <ArticleId IdType="pubmed">29774138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: from delusion to definition. Clin Cosmet Investig Dermatol. 2018;11:71‐90. doi:10.2147/CCID.S152343
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S152343</ArticleId>
            <ArticleId IdType="pmc">PMC5811176</ArticleId>
            <ArticleId IdType="pubmed">29467580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pearson ML, Selby JV, Katz KA, et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012;7(1):e29908. doi:10.1371/journal.pone.0029908
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0029908</ArticleId>
            <ArticleId IdType="pmc">PMC3266263</ArticleId>
            <ArticleId IdType="pubmed">22295070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Stricker RB. Morgellons disease: a filamentous borrelial dermatitis. Int J Gen Med. 2016;9:349‐354. doi:10.2147/IJGM.S116608
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJGM.S116608</ArticleId>
            <ArticleId IdType="pmc">PMC5072536</ArticleId>
            <ArticleId IdType="pubmed">27789971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hylwa SA, Ronkainen SD. Delusional infestation versus Morgellons disease. Clin Dermatol. 2018;36(6):714‐718. doi: 10.1016/j.clindermatol.2018.08.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clindermatol.2018.08.007</ArticleId>
            <ArticleId IdType="pubmed">30446193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yan BY, Jorizzo JL. Management of Morgellons disease with low‐dose trifluoperazine. JAMA Dermatol. 2018;154(2):216‐218. doi:10.1001/jamadermatol.2017.5175
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamadermatol.2017.5175</ArticleId>
            <ArticleId IdType="pmc">PMC5839272</ArticleId>
            <ArticleId IdType="pubmed">29322188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Al‐Imam A. A case report of Morgellons disease. Iran J Psychiatry Behav Sci. 2018;12(1):e9170. doi:10.5812/ijpbs.9170
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5812/ijpbs.9170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Reid E, Lio P. Successful treatment of Morgellons disease with pimozide therapy. Arch Dermatol. 2010;146(10):1191‐1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20956673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gartner AM, Dolan SL, Stanford MS, Elkins GR. Hypnosis in the treatment of Morgellons disease: a case study. Int J Clin Exp Hypn. 2011;59(2):242‐249. doi:10.1080/00207144.2011.546263
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00207144.2011.546263</ArticleId>
            <ArticleId IdType="pmc">PMC3907185</ArticleId>
            <ArticleId IdType="pubmed">21390982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Stricker RB. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. Clin Cosmet Investig Dermatol. 2011;4:167‐177. doi:10.2147/CCID.S26183
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S26183</ArticleId>
            <ArticleId IdType="pmc">PMC3257881</ArticleId>
            <ArticleId IdType="pubmed">22253541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013;6:1‐21. doi: 10.2147/CCID.S39017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S39017</ArticleId>
            <ArticleId IdType="pmc">PMC3544355</ArticleId>
            <ArticleId IdType="pubmed">23326202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 1992;166(2):440‐444. doi:10.1093/infdis/166.2.440
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/166.2.440</ArticleId>
            <ArticleId IdType="pubmed">1634816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Savely VR, Stricker RB. Morgellons disease: analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clin Cosmet Investig Dermatol. 2010;3:67‐78. doi:10.2147/ccid.s9520
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/ccid.s9520</ArticleId>
            <ArticleId IdType="pmc">PMC3047951</ArticleId>
            <ArticleId IdType="pubmed">21437061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Centers for Disease Control and Prevention
. 2021. Lyme disease treatment | CDC. [online] Available at: &lt;https://www.cdc.gov/lyme/treatment/index.html&gt;</Citation>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Bandoski C, Burke J, et al. Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients. BMC Dermatol. 2015;15(1):1. doi:10.1186/s12895-015-0023-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12895-015-0023-0</ArticleId>
            <ArticleId IdType="pmc">PMC4328066</ArticleId>
            <ArticleId IdType="pubmed">25879673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayne P, English JS, Kilbane EJ, et al. Morgellons: a novel dermatological perspective as the multisystem infective disease borreliosis [version 1; peer review: 1 approved, 1 approved with reservations, 2 not approved]. F1000Research. 2013;2:118. 10.12688/f1000research.2-118.v1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research.2-118.v1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lyme disease, molecular detection, PCR, blood. Mayo Clinic Laboratories. 2021. Accessed October 2, 2021. https://www.mayocliniclabs.com/test‐catalog/Clinical+and+Interpretive/87973
</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34917368</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2050-0904</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>9</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical case reports</Title>
          <ISOAbbreviation>Clin Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Treatment of Morgellons disease with doxycycline.</ArticleTitle>
        <Pagination>
          <StartPage>e05148</StartPage>
          <MedlinePgn>e05148</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e05148</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ccr3.5148</ELocationID>
        <Abstract>
          <AbstractText>Morgellons disease (MD) is a rare dermatopathy characterized by nonspecific symptoms and the production of multicolored fibers and granular tissue from diffuse skin ulcerations which are described as being either pruritic or painful. The etiology of MD is currently unknown; previous studies have suggested both psychiatric and infectious causes, with increasing interest over the previous decade in elaborating a possible pathogenesis for the disease secondary to infection by Borrelia species. We report a middle-aged Caucasian female who developed symptoms of MD in the days following exposure to a tick bite after spending an afternoon hiking through a wooded area. She was subsequently treated with a course of Doxycycline and found on two-week follow-up to have complete remission of her symptoms. This case report further supports the theory for an infectious etiology of MD and encourages future studies into its pathophysiology.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. Clinical Case Reports published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jeff F</ForeName>
            <Initials>JF</Initials>
            <Identifier Source="ORCID">0000-0003-0898-5871</Identifier>
            <AffiliationInfo>
              <Affiliation>Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gopalakrishnan</LastName>
            <ForeName>Keerthy</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>SRM Medical College Hospital and Research Centre Kattankulathur Kanchipuram India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Molloy</LastName>
            <ForeName>Daniel J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>St. Vincent Health Center, Sisters of Charity Hospital Buffalo New York USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Case Rep</MedlineTA>
        <NlmUniqueID>101620385</NlmUniqueID>
        <ISSNLinking>2050-0904</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Borrelia burgdorferi</Keyword>
        <Keyword MajorTopicYN="N">Doxycycline</Keyword>
        <Keyword MajorTopicYN="N">Lyme disease</Keyword>
        <Keyword MajorTopicYN="N">Morgellons disease</Keyword>
        <Keyword MajorTopicYN="N">dermatopathology</Keyword>
        <Keyword MajorTopicYN="N">spirochetes</Keyword>
      </KeywordList>
      <CoiStatement>The authors of this manuscript declare no conflicts of interest involving any of the materials or findings related to this research project.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>56</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34917368</ArticleId>
        <ArticleId IdType="pmc">PMC8643125</ArticleId>
        <ArticleId IdType="doi">10.1002/ccr3.5148</ArticleId>
        <ArticleId IdType="pii">CCR35148</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Robles DT, Olson JM, Combs H, Romm S, Kirby P. Morgellons disease and delusions of parasitosis. Am J Clin Dermatol. 2011;12(1):1‐6. doi:10.2165/11533150-000000000-00000
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/11533150-000000000-00000</ArticleId>
            <ArticleId IdType="pubmed">21110523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatol Rep. 2018;10(1):7660. doi:10.4081/dr.2018.7660
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/dr.2018.7660</ArticleId>
            <ArticleId IdType="pmc">PMC5941186</ArticleId>
            <ArticleId IdType="pubmed">29774138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: from delusion to definition. Clin Cosmet Investig Dermatol. 2018;11:71‐90. doi:10.2147/CCID.S152343
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S152343</ArticleId>
            <ArticleId IdType="pmc">PMC5811176</ArticleId>
            <ArticleId IdType="pubmed">29467580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pearson ML, Selby JV, Katz KA, et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012;7(1):e29908. doi:10.1371/journal.pone.0029908
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0029908</ArticleId>
            <ArticleId IdType="pmc">PMC3266263</ArticleId>
            <ArticleId IdType="pubmed">22295070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Stricker RB. Morgellons disease: a filamentous borrelial dermatitis. Int J Gen Med. 2016;9:349‐354. doi:10.2147/IJGM.S116608
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJGM.S116608</ArticleId>
            <ArticleId IdType="pmc">PMC5072536</ArticleId>
            <ArticleId IdType="pubmed">27789971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hylwa SA, Ronkainen SD. Delusional infestation versus Morgellons disease. Clin Dermatol. 2018;36(6):714‐718. doi: 10.1016/j.clindermatol.2018.08.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clindermatol.2018.08.007</ArticleId>
            <ArticleId IdType="pubmed">30446193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yan BY, Jorizzo JL. Management of Morgellons disease with low‐dose trifluoperazine. JAMA Dermatol. 2018;154(2):216‐218. doi:10.1001/jamadermatol.2017.5175
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamadermatol.2017.5175</ArticleId>
            <ArticleId IdType="pmc">PMC5839272</ArticleId>
            <ArticleId IdType="pubmed">29322188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Al‐Imam A. A case report of Morgellons disease. Iran J Psychiatry Behav Sci. 2018;12(1):e9170. doi:10.5812/ijpbs.9170
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5812/ijpbs.9170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Reid E, Lio P. Successful treatment of Morgellons disease with pimozide therapy. Arch Dermatol. 2010;146(10):1191‐1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20956673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gartner AM, Dolan SL, Stanford MS, Elkins GR. Hypnosis in the treatment of Morgellons disease: a case study. Int J Clin Exp Hypn. 2011;59(2):242‐249. doi:10.1080/00207144.2011.546263
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00207144.2011.546263</ArticleId>
            <ArticleId IdType="pmc">PMC3907185</ArticleId>
            <ArticleId IdType="pubmed">21390982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Stricker RB. Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. Clin Cosmet Investig Dermatol. 2011;4:167‐177. doi:10.2147/CCID.S26183
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S26183</ArticleId>
            <ArticleId IdType="pmc">PMC3257881</ArticleId>
            <ArticleId IdType="pubmed">22253541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013;6:1‐21. doi: 10.2147/CCID.S39017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CCID.S39017</ArticleId>
            <ArticleId IdType="pmc">PMC3544355</ArticleId>
            <ArticleId IdType="pubmed">23326202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 1992;166(2):440‐444. doi:10.1093/infdis/166.2.440
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/166.2.440</ArticleId>
            <ArticleId IdType="pubmed">1634816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Savely VR, Stricker RB. Morgellons disease: analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clin Cosmet Investig Dermatol. 2010;3:67‐78. doi:10.2147/ccid.s9520
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/ccid.s9520</ArticleId>
            <ArticleId IdType="pmc">PMC3047951</ArticleId>
            <ArticleId IdType="pubmed">21437061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Centers for Disease Control and Prevention
. 2021. Lyme disease treatment | CDC. [online] Available at: &lt;https://www.cdc.gov/lyme/treatment/index.html&gt;</Citation>
        </Reference>
        <Reference>
          <Citation>
Middelveen MJ, Bandoski C, Burke J, et al. Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients. BMC Dermatol. 2015;15(1):1. doi:10.1186/s12895-015-0023-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12895-015-0023-0</ArticleId>
            <ArticleId IdType="pmc">PMC4328066</ArticleId>
            <ArticleId IdType="pubmed">25879673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayne P, English JS, Kilbane EJ, et al. Morgellons: a novel dermatological perspective as the multisystem infective disease borreliosis [version 1; peer review: 1 approved, 1 approved with reservations, 2 not approved]. F1000Research. 2013;2:118. 10.12688/f1000research.2-118.v1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12688/f1000research.2-118.v1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lyme disease, molecular detection, PCR, blood. Mayo Clinic Laboratories. 2021. Accessed October 2, 2021. https://www.mayocliniclabs.com/test‐catalog/Clinical+and+Interpretive/87973
</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
